Bacteroides uniformis degrades β-glucan to promote Lactobacillus johnsonii improving indole-3-lactic acid levels in alleviating colitisOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study investigated how the dietary fiber beta-glucan (BG) helps improve colitis and examined the microbial and metabolic mechanisms behind that benefit. The researchers used multi-omics analysis along with validation experiments and loss-of-function studies to trace how BG intervention changes gut bacteria and their metabolites. They specifically focused on a cross-feeding interaction between two gut bacterial species and the downstream metabolite it produces.
Who was studied?
The abstract describes work in colitic mice, indicating the core experiments were conducted in a mouse model of colitis. A proof-of-concept study was also performed to confirm the bacterial and metabolite findings. The abstract does not provide details on the number of animals, strains used, or any human cohort, so no further population specifics can be stated.
What were the most important findings?
BG intervention ameliorated colitis and reversed the reduction in Lactobacillus seen in colitic mice, with Lactobacillus abundance negatively correlated with colitis severity. Lactobacillus johnsonii was identified as the most significantly enriched Lactobacillus species, and it produced abundant indole-3-lactic acid (ILA), which activated the aryl hydrocarbon receptor (AhR) to mitigate colitis. Notably, L. johnsonii could not use BG directly but instead relied on cross-feeding with Bacteroides uniformis, which degrades BG and generates nicotinamide (NAM) to support L. johnsonii growth. The proof-of-concept study confirmed that BG increased the abundance of both L. johnsonii and B. uniformis along with ILA levels.
What are the greatest implications of this study?
The findings reveal a previously unrecognized bacterial cross-feeding pathway in which one species degrades dietary fiber to feed a beneficial partner species that produces a protective metabolite. This suggests that dietary beta-glucan could be explored as a way to reshape gut microbial interactions and boost protective indole metabolite production in inflammatory bowel disease. It also highlights indole-3-lactic acid and AhR activation as a potential mechanistic target for future colitis-related interventions.